These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8829276)

  • 1. Radioiodine and thyroid disease: the beginning.
    Becker DV; Sawin CT
    Semin Nucl Med; 1996 Jul; 26(3):155-64. PubMed ID: 8829276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine and the treatment of hyperthyroidism: the early history.
    Sawin CT; Becker DV
    Thyroid; 1997 Apr; 7(2):163-76. PubMed ID: 9133679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robley Evans and what physics can do for medicine.
    Adelstein SJ
    Cancer Biother Radiopharm; 2001 Jun; 16(3):179-85. PubMed ID: 11471483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saul Hertz, MD (1905-1950): a pioneer in the use of radioactive iodine.
    Hertz BE; Schuller KE
    Endocr Pract; 2010; 16(4):713-5. PubMed ID: 20350908
    [No Abstract]   [Full Text] [Related]  

  • 5. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
    Jarløv AE; Hegedüs L; Kristensen LO; Nygaard B; Hansen JM
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):325-9. PubMed ID: 7586602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
    Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the field of thyroid endocrinology developed in France after World War II.
    Fragu P
    Bull Hist Med; 2003; 77(2):393-414. PubMed ID: 12955965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option].
    Jiskra J; Kubinyi J; Telička Z
    Vnitr Lek; 2012 Feb; 58(2):94-8. PubMed ID: 22463087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early history (1936--1946) of nuclear medicine in thyroid studies at Massachusetts General Hospital.
    Evans RD
    Med Phys; 1975; 2(3):105-9. PubMed ID: 1102906
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiation dose to patients and relatives incident to 131I therapy.
    Zanzonico PB
    Thyroid; 1997 Apr; 7(2):199-204. PubMed ID: 9133684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.
    Mattsson S; Johansson L; Jönsson H; Nosslin B
    Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine treatment of solitary functioning thyroid nodules.
    Ratcliffe GE; Cooke S; Fogelman I; Maisey MN
    Br J Radiol; 1986 Apr; 59(700):385-7. PubMed ID: 3697616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioiodine treatment of benign thyroid diseases].
    Konrády A
    Orv Hetil; 2006 Sep; 147(37):1783-9. PubMed ID: 17131798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine: the classic theranostic agent.
    Silberstein EB
    Semin Nucl Med; 2012 May; 42(3):164-70. PubMed ID: 22475425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid fine-needle aspiration biopsy: which lesions should be biopsied before 131I therapy?
    Listewnik MH; Birkenfeld B; Chosia M; Elbl B; Piwowarska-Bilska H; Zorga P; Niedziałkowska K
    Ann Acad Med Stetin; 2011; 57(1):54-8. PubMed ID: 22593992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of radioiodine therapy on urinary iodine excretion.
    Meller B; Lauer I; Bähre M; Richter E
    Nuklearmedizin; 1998 May; 37(3):107-12. PubMed ID: 9604231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiometabolic therapy of the autonomous thyroid nodule].
    Mariotti S; Caturegli P; Barbesino G; Ceccarelli C; Lippi F; Marinò M; Manetti L; Martino E; Pinchera A
    Minerva Endocrinol; 1993 Dec; 18(4):155-63. PubMed ID: 8190055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
    Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
    J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.